A national survey of 1,700 Americans aged 45 and older reveals strong interest in early detection and treatment for Alzheimer's disease. The Alzheimer's Association report indicates that 79% of respondents want to know their status before symptoms interfere, while 80% would actively seek testing. There is a significant willingness to embrace treatment options; 92% would opt for drugs to slow the disease, and 83% are open to clinical trials. Despite their eagerness, many are unaware of existing blood tests that can indicate the disease's presence and worry about insurance coverage for treatment.
Older Americans are becoming less afraid and more proactive about Alzheimer's diagnosis, as demonstrated by a national survey revealing a strong desire for testing and treatment.
Nearly four in five respondents (79%) would want to know they had Alzheimer's before symptoms interfere with daily activities, highlighting a shift in mindset.
92% of respondents expressed willingness to take drugs that could slow the progression of Alzheimer's if diagnosed, showcasing openness to treatment options.
The majority of older Americans (91%) indicated they would prefer a blood test or some simple test for Alzheimer's, however, many were unaware of existing tests.
Collection
[
|
...
]